Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications

E-ISSN： 1873-4286|22|18|2689-2696

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.18, 2016-05, pp. : 2689-2696

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular mechanisms of resistance to taxanes and therapeutic implications

By Zunino F. Cassinelli G. Polizzi D. Perego P.

Drug Resistance Updates, Vol. 2, Iss. 6, 1999-12 ,pp. : 351-357

Academic Press

Access to resources Recommend Favorite

Regulation of MET Receptor Signaling by SOCS1 and its Implications for Hepatocellular Carcinoma

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2922-2933

Bentham Science Publishers

Access to resources Recommend Favorite

An Updated Portrait of Pathogenesis, Molecular Markers and Signaling Pathways of Hepatocellular Carcinoma

Current Pharmaceutical Design, Vol. 23, Iss. 16, 2017-06 ,pp. : 2356-2365

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Dysfunction as the Molecular Basis of Bipolar Disorder: Therapeutic Implications

By Kato Tadafumi

CNS Drugs, Vol. 21, Iss. 1, 2007-01 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

Lymphocyte trafficking to inflamed skin – molecular mechanisms and implications for therapeutic target molecules

By Schön Michael P Ludwig Ralf J

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 225-243

Informa Healthcare

Access to resources Recommend Favorite